Unlock instant, AI-driven research and patent intelligence for your innovation.

Quinazoline compound as well as preparation method and application thereof

A compound, technology of dimethoxyquinazoline, applied in the field of medicine

Active Publication Date: 2015-04-08
上海懿峰生物科技有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are still some problems with these inhibitors. For example, they are all competitive inhibitors of ATP, and the ATP concentration in cells, especially cancer cells, can reach more than 5 mmol / L, so the inhibitor activity should at least reach nanomolar levels. to exhibit an effective inhibitory effect on

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Quinazoline compound as well as preparation method and application thereof
  • Quinazoline compound as well as preparation method and application thereof
  • Quinazoline compound as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0072] Preparation of 6,7-dimethoxy-4-(1,2,3,4-tetrahydroquinoline-6oxy)quinazoline (Ⅱ)

[0073] Add 22.5g (100.2mmol) of 4-chloro-6,7-dimethoxyquinazoline, 250ml of butanone, 16.5g (51mmol) of tetrabutylammonium bromide, and 20% sodium hydroxide solution into a 500ml round bottom bottle 120ml, stirred at room temperature for 2 minutes, another 15g (100.5mmol) of 6-hydroxy-1,2,3,4-tetrahydroquinoline was taken, stirred, heated to reflux, reacted for 1 hour, TLC followed the reaction (petroleum ether was used as the developer : ethyl acetate=2.5:2.5), complete reaction. post-processing.

[0074] The reaction solution was transferred to a separatory funnel, the water layer was separated, the organic layer was washed twice by adding 50 ml of water, the organic layer was left to stand, and light yellow crystals slowly precipitated, filtered to obtain 28 g of dry solid. Butanone was refined to obtain 22g of pure product. Yield: 65.3%.

[0075] 1 HNMR (600MHz, CDCl 3 )δ8.65(s,...

Embodiment 2

[0076] Embodiment 2 (synthesis of ZLZ-KZL-01)

[0077] Add 0.5g (1.5mmol) of 6,7-dimethoxy-4-(1,2,3,4-tetrahydroquinoline-6oxy)quinazoline and 10ml of chloroform into a 100ml round bottom bottle, dissolve, Stir at room temperature, take another 0.45g (3.0mmol) of 2-isopropylphenylisocyanate in 2ml of chloroform until dissolved, slowly add to the round bottom bottle after dissolving, react at room temperature for 1 hour, follow the reaction by TLC (the developer is petroleum Ether: ethyl acetate = 1.5:3.0), after 2 hours of reaction at room temperature, it became light yellow and turbid, and it was reacted at room temperature for 48 hours before post-treatment.

[0078] The reaction solution was transferred to a separatory funnel, 10ml of water was added to the chloroform layer and shaken and washed twice, the chloroform layer was washed once with 5ml of saturated sodium bicarbonate solution, and 10ml of water was added to shake and washed twice, and the chloroform layer was wa...

Embodiment 3

[0080] Embodiment 3 (synthesis of ZLZ-KZL-02)

[0081] Add 0.5g (1.5mmol) of 6,7-dimethoxy-4-(1,2,3,4-tetrahydroquinoline-6oxy)quinazoline and 10ml of chloroform into a 100ml round bottom bottle, dissolve, Stir at room temperature, take another 0.47g (3.0mmol) of tert-octyl isocyanate in 2ml of chloroform until dissolved, slowly add to the round bottom bottle after dissolving, react at room temperature for 1 hour, follow the reaction by TLC (developing agent is petroleum ether: acetic acid Ethyl ester=2.5:2.5), react at room temperature for 30 hours, and post-treatment.

[0082] The reaction solution was transferred to a separatory funnel, 10ml of water was added to the chloroform layer and shaken and washed twice, the chloroform layer was washed once with 5ml of saturated sodium bicarbonate solution, and 10ml of water was added to shake and washed twice, and the chloroform layer was washed with anhydrous magnesium sulfate 1.5 g was dried for 1 hour, filtered, most of the chlor...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the field of medical technology, in particular to a class of quinazoline tyrosine kinase inhibitors, their preparation method and their application in the preparation of antitumor drugs, the compounds have a general structural formula (I): the present invention discloses The compounds have good tyrosine kinase inhibitory activity, especially VEGFR1, VEGFR2 and VEGFR3 inhibitory activity, and some preferred compounds have also been studied on the metabolic rate of liver microsomes and the absorption characteristics in the Caco-2 model.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a class of quinazoline tyrosine kinase inhibitors, a preparation method thereof and the application thereof in the preparation of antitumor drugs. Background technique [0002] Malignant tumors are one of the major diseases that seriously affect human health and threaten human life. Both the World Health Organization and government health departments of various countries have listed cancer as a top priority. At present, the anticancer drugs commonly used in clinical practice are mainly cytotoxic drugs. Due to the inherent nature of cytotoxicity, these drugs have unavoidable disadvantages such as poor selectivity, strong side effects, and easy drug resistance. Therefore, finding new targets with high specificity, low toxicity, and good patient tolerance has become an urgent need for anticancer drug research. In recent years, with the rapid development of life science research, m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D401/12C07D405/14A61K31/517A61P35/00
CPCC07D401/12C07D405/14A61K31/517A61P35/00
Inventor 不公告发明人
Owner 上海懿峰生物科技有限公司